476 related articles for article (PubMed ID: 8829017)
1. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
Clin Ther; 1996; 18(4):608-25. PubMed ID: 8879890
[TBL] [Abstract][Full Text] [Related]
3. A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
Conlin PR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
J Hum Hypertens; 1998 Oct; 12(10):693-9. PubMed ID: 9819017
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
Townsend R; Haggert B; Liss C; Edelman JM
Clin Ther; 1995; 17(5):911-23. PubMed ID: 8595643
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
[TBL] [Abstract][Full Text] [Related]
7. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
Manolis AJ; Grossman E; Jelakovic B; Jacovides A; Bernhardi DC; Cabrera WJ; Watanabe LA; Barragan J; Matadamas N; Mendiola A; Woo KS; Zhu JR; Mejia AD; Bunt T; Dumortier T; Smith RD
Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
[TBL] [Abstract][Full Text] [Related]
8. Losartan potassium as initial therapy in patients with severe hypertension.
Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
10. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
Raskin P; Guthrie R; Flack J; Reeves R; Saini R
J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
[TBL] [Abstract][Full Text] [Related]
11. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
Oparil S; Levine JH; Zuschke CA; Gradman AH; Ripley E; Jones DW; Hardison JD; Cushing DJ; Prasad R; Michelson EL
Am J Cardiol; 1999 Aug; 84(3):289-93. PubMed ID: 10496437
[TBL] [Abstract][Full Text] [Related]
12. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
Oparil S; Aurup P; Snavely D; Goldberg A
Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
[TBL] [Abstract][Full Text] [Related]
14. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
[TBL] [Abstract][Full Text] [Related]
15. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
Fogari R; Mugellini A; Derosa G;
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):139-44. PubMed ID: 17907102
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
Chrysant SG; Weber MA; Wang AC; Hinman DJ
Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension.
Gradman AH; Brady WE; Gazdick LP; Lyle P; Zeldin RK
Clin Ther; 2002 Jul; 24(7):1049-61. PubMed ID: 12182251
[TBL] [Abstract][Full Text] [Related]
19. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
Oparil S; Guthrie R; Lewin AJ; Marbury T; Reilly K; Triscari J; Witcher JA
Clin Ther; 1998; 20(3):398-409. PubMed ID: 9663357
[TBL] [Abstract][Full Text] [Related]
20. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
Isles CG; Kitchin NR
J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
